Literature DB >> 28470201

Erratum: Effective combinatorial immunotherapy for castration-resistant prostate cancer.

Xin Lu, James W Horner, Erin Paul, Xiaoying Shang, Patricia Troncoso, Pingna Deng, Shan Jiang, Qing Chang, Denise J Spring, Padmanee Sharma, John A Zebala, Dean Y Maeda, Y Alan Wang, Ronald A DePinho.   

Abstract

Entities:  

Year:  2017        PMID： 28470201     DOI： 10.1038/nature22348

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  1 in total

1.  Effective combinatorial immunotherapy for castration-resistant prostate cancer.

Authors:  Xin Lu; James W Horner; Erin Paul; Xiaoying Shang; Patricia Troncoso; Pingna Deng; Shan Jiang; Qing Chang; Denise J Spring; Padmanee Sharma; John A Zebala; Dean Y Maeda; Y Alan Wang; Ronald A DePinho
Journal:  Nature       Date:  2017-03-20       Impact factor: 49.962
  1 in total
  3 in total

1.  KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal Cancer.

Authors:  Wenting Liao; Michael J Overman; Adam T Boutin; Xiaoying Shang; Di Zhao; Prasenjit Dey; Jiexi Li; Guocan Wang; Zhengdao Lan; Jun Li; Ming Tang; Shan Jiang; Xingdi Ma; Peiwen Chen; Riham Katkhuda; Krittiya Korphaisarn; Deepavali Chakravarti; Andrew Chang; Denise J Spring; Qing Chang; Jianhua Zhang; Dipen M Maru; Dean Y Maeda; John A Zebala; Scott Kopetz; Y Alan Wang; Ronald A DePinho
Journal:  Cancer Cell       Date:  2019-03-21       Impact factor: 31.743

2.  Cytokine and Chemokine Receptor Patterns of Human Malignant Melanoma Cell Lines.

Authors:  Viktoria Koroknai; István Szász; Krisztina Jámbor; Margit Balázs
Journal:  Int J Mol Sci       Date:  2022-02-28       Impact factor: 5.923

3.  Exploring the synergistic effects of cabozantinib and a programmed cell death protein 1 inhibitor in metastatic renal cell carcinoma with machine learning.

Authors:  Ignacio Durán; Daniel Castellano; Javier Puente; Lidia Martín-Couce; Esther Bello; Urbano Anido; José Manuel Mas; Luis Costa
Journal:  Oncotarget       Date:  2022-01-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.